The market expects Collegium Pharmaceutical (COLL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known ...

Shares of pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) fell 6.7% in the afternoon session after the company ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) will be reporting results this Thursday before market open.

Book cover courtesy of Susan Coll. Susan Coll was already an established novelist when she started working at Politics and Prose in 2011, and she promised the store’s owners that she wouldn’t write ...

Detailed price information for Collegium Pharma (COLL-Q) from The Globe and Mail including charting and trades.

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...